Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Mineralys Therapeutics (NASDAQ: MLYS) said management will participate in the Bank of America Securities 2026 Health Care Conference in Las Vegas on May 12, 2026 at 9:20am PT in a fireside chat.
A live webcast will be available via the company’s Investor Relations "News & Events" page.
Details
News Market Reaction – MLYS
On May 5, the day this news came out, MLYS closed 1.25% below the previous close.
Data tracked by StockTitan Argus for the May 5 session.
Key Figures
- Conference dates
- May 11–14, 2026
- Bank of America Securities Health Care Conference
- Presentation date
- May 12, 2026
- Scheduled conference fireside chat
- Presentation time
- 9:20 a.m. PT
- Fireside chat session at conference
Historical Context
-
Set date and time for Q1 2026 results call and webcast.
-
Appointed Jeffrey A. Munsie as Chief Legal Officer with equity awards.
-
Reported stock option and RSU inducement grants to a new employee.
-
Reported Q4 2025 results, NDA acceptance, cash position, and trial updates.
-
Announced FDA NDA acceptance for lorundrostat and topline Explore-OSA data.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
chronic kidney disease (ckd) medical
obstructive sleep apnea (osa) medical
aldosterone medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced that management will be participating in the Bank of America Securities 2026 Health Care Conference being held in Las Vegas on May 11-14, 2026.
| Bank of America Securities Health Care Conference | |
| Date: | Tuesday, May 12, 2026 |
| Time: | 9:20am PT |
| Format: | Fireside Chat |
| Webcast Link | |
A live webcast of this fireside chat can also be accessed on the “News & Events” page in the Investor Relations section of the Mineralys Therapeutics website.
About Mineralys Therapeutics
Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as CKD, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky.
Contact:
Investor Relations
investorrelations@mineralystx.com
Media Relations
Melyssa Weible
Elixir Health Public Relations
Email: mweible@elixirhealthpr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.